How Genomics can assist in offering personalized treatments?
Fagron Genomics is participating in the IMCAS World Congress, the biggest medical conference bringing together international experts in plastic surgery, dermatology and aesthetic science. The IMCAS World Congress will be held in Paris, France, from January 30th to February 1st. We are looking forward to exchange experiences, learn from, and connect with all participants, and to present how Fagron Genomics is letting genes trigger treatments.
The 22nd edition of IMCAS World Congress will address youth & age in dermatology, plastic surgery and aesthetic science. With 300 exhibitors, more than 800 speakers and 12000 attendees, IMCAS is the most important international destination for industry experts in plastic and reconstructive surgery and dermatology.
Fagron Genomics enables medical professionals to offer personalized primary pharmaceutical solutions by use of pharmacogenetics and diagnostic molecular analysis. Fagron Genomics develops genetic tests and biomedical analyses to assist prescribers to diagnose, prevent and treat focusing on identification of genetic variations for more effective personalized treatments of conditions, such as alopecia. We welcome all participants to visit us at booth N118A to talk about the future of genomics and how it can assist in offering personalized treatments to patients.
